Barclays PLC Avrobio, Inc. Put Options Transaction History
Barclays PLC
- $377 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AVRO
# of Institutions
1Shares Held
559KCall Options Held
0Put Options Held
0About AVROBIO, Inc.
- Ticker AVRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,773,900
- Description
- AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...